Development pipeline

Development code;
Target/Indication(s)
Target exploration Optimization
(sequence, type of nucleic acid)
Efficacy, toxicity, metabolism studies, etc.
(Preliminary nonclinical studies)
Non-clinical studies Phase I
BNC-1021/TRK-250;
TGF-β1/IPF
BNC-1321;
TGF-β1/COVID-19,ARDS
-
BNC-1601;
(pro)renin receptor/AMD, Uveitis, Diabetic retinopathy
- -
BNC-1701;
Virus/HBV
- -
BNC-1602;
miR29b/liver fibrosis
- -
BNC-1322;
SARS-CoV-2/COVID-19
- - -
BNC-1071;
Not disclosed
- - - -

ページ上部へ